Feeling Is Believing: Evaluative Conditioning and the Ethics of Pharmaceutical Advertising
- 859 Downloads
A central goal in regulating direct-to-consumer advertising of prescription pharmaceuticals (DTCA) is to ensure that explicit drug claims are truthful. Yet imagery can also alter viewer attitudes, and the degree to which this occurs in DTCA is uncertain. Addressing this data gap, we provide evidence that positive feelings produced by images can promote favourable beliefs about pharmaceuticals. We had participants view a fictitious anti-influenza drug paired with unrelated images that elicited either positive, neutral or negative feelings. Participants who viewed positive images rated the influenza drug as significantly more effective, safe, and beneficial than did participants who viewed negative images. This effect, known as evaluative conditioning, is well described in experimental social psychology but has not previously been shown with pharmaceuticals. We discuss how evaluative conditioning in DTCA may compromise viewer autonomy, and canvass possible regulatory responses.
KeywordsAutonomy Behavioural research Drugs and drug industry Health promotion Informed consent
- Aikin, K.J., J.L. Swasy, and A.C. Braman. 2004. Patient and physician attitudes and behaviors associated with DTC promotion of prescription drugs—summary of FDA survey research results. Silver Spring, MD: U.S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research. http://www.fda.gov/downloads/Drugs/ScienceResearch/ResearchAreas/DrugMarketingAdvertisingandCommunicationsResearch/UCM152860.pdf.
- Bradley, M.M., and P.J. Lang. 2007. The international affective digitized sounds: Affective ratings of sounds and instruction manual, 2nd ed., IADS-2. Gainesville: University of Florida.Google Scholar
- De Houwer, J. 2009. Conditioning as a source of liking: There is nothing simple about it. In Social psychology of consumer behavior, edited by M. Wanke, 151–166. New York: Taylor and Francis.Google Scholar
- Faden, R.R., T.L. Beauchamp, and N.M.P. King. 1986. A history and theory of informed consent. New York: Oxford University Press.Google Scholar
- Food and Drug Administration. 2007. Improving public health through human drugs. Silver Spring, MD: Center for Drug Evaluation and Research.Google Scholar
- Food and Drug Administration. 2009. Guidance for industry: Presenting risk information in prescription drug and medical device promotion. Rockville: Center for Drug Evaluation and Research.Google Scholar
- Food and Drug Administration. 2011. A supplementary test of distraction in DTC advertising using an implicit measure, the affect misattribution procedure. Silver Spring, MD: Center for Drug Evaluation and Research.Google Scholar
- Food and Drug Administration. 2012. Be smart about prescription drug advertising: A guide for consumers. http://www.fda.gov/Drugs/ResourcesForYou/Consumers/PrescriptionDrugAdvertising/. Accessed June 16, 2015.
- Food and Drug Administration. 2015. The Office of Prescription Drug Promotion (OPDP). http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm090142.htm. Accessed June 16, 2015.
- Hayes, A.F. 2013. An introduction to mediation, moderation, and conditional process analysis: A regression-based approach. New York: The Guilford Press.Google Scholar
- Lang P.J., M.M. Bradley, and B.N. Cuthbert. 2008. International affective picture system (IAPS): Affective ratings of pictures and instruction manual. Gainesville, FL: University of Florida, technical report A-8.Google Scholar
- Paolacci, G., J. Chandler, and P.G. Ipeirotis. 2010. Running experiments on Amazon Mechanical Turk. Judgment and Decision Making 5(5): 411–419.Google Scholar
- Pfizer. Lipitor Medication. 2010. [Commercial]. http://www.youtube.com/watch?v=ogyC9rEjxDM. Accessed June 16, 2015.
- Pleyers, G., O. Corneille, O. Luminet, and V. Yzerbyt. 2007. Aware and (dis)liking: Item-based analyses reveal that valence acquisition via evaluative conditioning emerges only when there is contingency awareness. Journal of Experimental Psychology: Learning, Memory, and Cognition 33(1): 130–144.PubMedGoogle Scholar
- Traylor, M. 1983. Ordinal and interval scaling. Journal of the Market Research Society 25(4): 297–303.Google Scholar
- Ventola, C.L. 2011. Direct-to-consumer pharmaceutical advertising: therapeutic or toxic? Pharmacy & Therapeutics 36(10): 669–684.Google Scholar